AlphAIalphai — Financial news for AI agents
Intellectia AIAPR 55 min read$SNDL

SNDL Financials: Revenue Breakdown, Margins & Competitor Comparison

This article provides an analysis of SNDL Inc.'s financial performance, focusing on its revenue breakdown, profitability margins, and a comparison with competitors. SNDL primarily generates revenue from liquor retail, and its gross margin is highlighted against other companies in the Pharmaceuticals industry. The analysis aims to help investors understand SNDL's market position and efficiency.

Original reporting
Intellectia AI
Published Apr 5, 2026, 5:10 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 5, 2026, 5:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefFinancial news
Primary signal
$SNDL
Neutral
medium confidence
Mentioned
$SNDL
alphai data visualization · based on Intellectia AI
Decision brief

The 30-second read

$SNDLNeutralLow
01

Why it matters

The company's margins are under pressure compared to industry peers, which could influence investor sentiment and stock performance.

02

Market read

The news provides insights into SNDL's financial health, relevant for traders interested in retail and pharma sectors, but limited for broader market movements.

03

What to watch

Potential regulatory changes or market disruptions in the retail and pharma sectors could significantly impact SNDL's performance.

Timing: short-term (next 1-2 weeks)

Background

SNDL operates mainly in liquor retail, with recent financials indicating stable revenue but moderate margins.

Company-level read

Ticker impact

$SNDLNeutralMedium confidence
Context

The article provides an analysis of SNDL Inc.'s financial performance, focusing on revenue breakdown, margins, and competitor comparison.

Expected impact

Limited immediate impact; potential for slight positive movement if margins improve or if market perceives strategic shifts favorably.

Evidence & confidence

The analysis is based on recent financial data and industry comparisons, but lacks current stock price and technical indicators, limiting predictive accuracy.

Market effects

Sector

The analysis suggests that SNDL's performance may influence the retail and pharmaceuticals sectors, especially if margins lead to strategic shifts.

Regional

Limited; primarily affecting North American retail and pharma segments.

Global

Minimal; SNDL's operations are regionally focused with limited global exposure.

Counterpoint

What could challenge this read

SNDL could leverage its retail margins to expand market share, leading to potential upside in the medium term.

Key entities

  • Company
    SNDL Inc.

    A retail company primarily engaged in liquor sales.

  • Industry
    Pharmaceutical Industry

    Sector benchmark for margin comparison.

Read at source← All news

Related articles

JUL 29
$SNDLMedAI 8/10

Alberta-based retailer hit by Canadians drinking less booze, smoking less weed

SNDL Inc, an Edmonton-based liquor and cannabis retailer, reported Q2 revenue down about 4% to $235.8 million and a nearly $8 million loss. Liquor sales fell about 5% to $134.7 million and cannabis store sales slipped 1.4% to $83.2 million. Management cited weaker Canadian demand and vape production issues, and said U.S. retail expansion in Florida, Texas and Massachusetts is pending.

calgarysun.com6 min
JUL 28
$SNDLMedAI 8/10

SNDL Reports Second Quarter 2026 Financial and Operational Results

SNDL Inc. reported Q2 2026 results for the quarter ended June 30, 2026. Net revenue fell 3.7% to C$235.8M and gross profit declined 16.6% to C$56.3M. Operating loss was C$(7.8)M. Cash flow was C$(30.2)M, with free cash flow C$(6.7)M. SNDL said it had C$183.2M unrestricted cash and no debt, and repurchased 11.7M shares. It also said a restructuring of Surterra’s Parallel is expected to give it control of medical cannabis operations in coming months.

leaderpost.com6 min
JUL 27
$SNDLMedAI 8/10

SNDL Announces Completion of Parallel Asset Acquisition and Positions for Nasdaq-Consolidated U.S. Medical Cannabis Operations

SNDL Inc. (NASDAQ: SNDL) said it completed the April 29, 2026 acquisition of assets from Surterra Holdings and affiliates via a strict foreclosure. The deal reduces about US$842 million of Parallel debt and gives SNDL indirect majority economic exposure equivalent to 66.7% of TransactionCo equity and 69.4% of debt. Acquired assets include 56 retail and 3 cultivation/manufacturing sites with about US$150 million annualized revenue.

leaderpost.com4 min
MAY 28
$CIAMedAI 8/10

Small caps to watch: Earnings from EQB, Coveo, Champion Iron and more

Canada’s S&P/TSX Small Cap Index is up about 67% over 52 weeks (record 1,472.68 on May 13), while the U.S. Russell 2000 is up about 40% (record 2,932.74 on Wednesday). EQB beat Q2 revenue/adjusted EPS but credit-loss provisions rose to $45.4M; revenue was $302–4M. Coveo’s Q4 matched expectations, but FY27 SaaS growth guidance (~9.5%) was seen below forecasts. Champion Iron Q4 revenue fell to $414.5M and net income to $23.2M. SNDL said its Ontario store purchase won’t proceed; it plans to realloc

theglobeandmail.com7 min